MammaPrint genetic test can reduce use of post-surgery chemotherapy among early-stage

[News]

Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological criteria, the MammaPrint genetic test identified a large group...

More... (http://www.medicalnewstoday.com/releases/309241.php)